98%
921
2 minutes
20
and genes involved in the development and signaling of B-cells are identified as susceptibility loci for numerous inflammatory diseases. Accordingly, we assessed the potential influence of and on the pathogenesis of immunoglobulin-A vasculitis (IgAV), predominantly a B-lymphocyte inflammatory condition. Three genetic variants within (rs1883832, rs1535045, rs4813003) and (rs2254546, rs2736340, rs2618476) as well as two polymorphisms (rs10516487, rs3733197), previously associated with inflammatory diseases, were genotyped in 382 Caucasian patients with IgAV and 955 sex- and ethnically matched healthy controls. No statistically significant differences were observed in the genotype and allele frequencies of and when IgAV patients and healthy controls were compared. Similar results were found when and genotypes or alleles frequencies were compared between patients with IgAV stratified according to the age at disease onset or to the presence/absence of gastrointestinal or renal manifestations. Moreover, no and haplotype differences were disclosed between patients with IgAV and healthy controls and between patients with IgAV stratified according to the clinical characteristics mentioned above. Our findings indicate that and do not contribute to the genetic background of IgAV.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572210 | PMC |
http://dx.doi.org/10.3390/jcm11195577 | DOI Listing |
Children (Basel)
August 2025
Department of Pediatric Nephrology, Faculty of Medicine, Ege University, Bornova, Izmir 35100, Turkey.
Background: IgA vasculitis (IgAV) represents the most frequently seen form of vasculitis among children. Although it often resolves without intervention, renal involvement (IgAV nephritis) poses a risk for long-term complications. Although the lectin and alternative complement pathways are possible causes in its development, dependable serum biomarkers for the early identification of nephritis remain unavailable.
View Article and Find Full Text PDFClin Rheumatol
August 2025
Division of Nephrology, Department of Pediatrics, School of Medicine, Kirikkale University, Kirikkale, 71450, Türkiye.
Background: IgA vasculitis (IGAV) is the most frequently encountered form of vasculitis in the pediatric population and typically follows a self-limiting course. In addition to well known inflammatory markers, several other inflammatory mediators, including Endocan, endothelial nitric oxide synthase (eNOS), and soluble CD89 (sCD89), have not been extensively investigated in the context of IGAV. The aim of this study was to evaluate the association between Endocan, endothelial nitric oxide synthase (eNOS), and soluble CD89 (sCD89) and established inflammatory markers (CRP, erythrocyte sedimentation rate), as well as their relationship with clinical manifestations and laboratory findings in pediatric patients diagnosed with IGAV.
View Article and Find Full Text PDFZhonghua Er Ke Za Zhi
September 2025
Department of Nephrology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Disease, Chongqi
To analyze the clinical features and risk factors for renal injury in children with antineutrophil cytoplasmic antibody (ANCA)-positive IgA vasculitis (IgAV). A case-control study was conducted. Seventy-two ANCA-positive IgAV children hospitalized at the Children's Hospital of Chongqing Medical University from January 2017 to October 2022 were enrolled as the ANCA-positive group.
View Article and Find Full Text PDFFront Pediatr
July 2025
Department of Pediatrics, the First People's Hospital of Lianyungang, The Affiliated Lianyungang Hospital of Xuzhou Medical University, The First Affiliated Hospital of Kangda College of Nanjing Medical University, Lianyungang Clinical College of Nanjing Medical University, Lianyungang, Jiangsu, Chi
Objective: To explore the risk factors associated with renal injury in patients diagnosed with IgA vasculitis at initial presentation.
Methods: A retrospective analysis was conducted on the clinical data of 384 children who were newly diagnosed with Immunoglobulin A vasculitis (IgAV) and hospitalized between July 2020 and June 2023. The participants were categorized into two groups based on whether their 24-hour urinary protein levels exceeded 150 mg upon admission.
Mol Med
July 2025
Immunopathology Group, Fundación Instituto de Investigación Marqués de Valdecilla, Santander, 39011, Spain.
Background: IgA-mediated vasculitis (IgAV) is a complex inflammatory disease. Unravelling its genetic background would allow us to identify genetic biomarkers that may be used as additional tools in its daily management, helping to solve the clinical challenge that this vasculitis entails. C5 is a potent immune mediator that is proteolytically processed to generate C5a, a potent anaphylatoxin that exerts its function via C5aR1.
View Article and Find Full Text PDF